Abstract
Immunoperoxidase staining for carcinoembryonic antigen (CEA) was performed on 192 colorectal carcinomas to determine: whether tissue staining can be substituted for preoperative serum CEA levels, and whether patient survival can be predicted by these parameters. The overall incidence of positive tissue staining was 75 percent, which was similar to the elevated serum level percentage of 73 percent. Both the serum CEA level and the CEA tissue stain correlated with patient survival in Dukes' stage C patients. There was no correlation between tissue CEA stain and tumor differentiation. Positive tissue stain and elevated preoperative serum CEA identified patients with poor prognosis in Dukes' stage D only. This study shows that tissue staining with immunoperoxidase may be substituted for preoperative serum levels for CEA. The combination of these two parameters, however, does not identify patients at greater risk for recurrence than either procedure alone.
Similar content being viewed by others
References
Wanebo HJ, Bhaskar R, Pinsky CM, et al. Preoperative carcinoembryonic level as a prognostic indicator in colorectal cancer. N Engl J Med 1978;299:448–51.
Herrera MA, Chu TM, Holyoke ED. Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg 1976;183:5–9.
Grinnell RS. The grading and prognosis of carcinoma of the colon and rectum. Ann Surg 1939;109:500–33.
Roseman DL, Straus AK. Staging of carcinoma of the colon and rectum. Surg Gynecol Obstet 1980;151:93–5.
Sternberger LA. Immunocytochemistry. 2nd ed. New York: John Wiley & Sons, 1979:104–9.
Hansen HJ, Snyder JJ, Miller E, et al. Carcinoembryonic antigen (CEA) assay: a laboratory adjunct in the diagnosis and management of cancer. Hum Pathol 1974;5:139–47.
Zamcheck N. The expanding field of colorectal cancer marker: CEA, the prototype. Cancer Bull 1981;33:141–51.
Sugarbaker PH, Skarin AT, Zamcheck N. Patterns of serial CEA assays and their clinical use in management of colorectal cancer. J Surg Oncol 1976;8:523–37.
Sugarbaker PH, Zamcheck N, Moore FD. Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer. Cancer 1976;38:2310–5.
Mayer RJ, Garnick MB, Steele GD, Zamcheck N. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer 1978;42:1428–33.
Sugarbaker PH, Bloomer WD, Corbett ED, Chaffey JT. Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancer. AJR 1976;127:641–4.
Zamcheck N, Doos WG, Prudente R, Lurie BB, Gottlieb LS. Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology. Hum Pathol 1975;6:31–45.
Goslin R, Steele G Jr, MacIntyre J, et al. The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann Surg 1980;192:747–51.
Midiri G, Amanti C, Consorti F, et al. Usefulness of preoperative CEA levels in the assessment of colorectal cancer patient stage. J Surg Oncol 1983;22:257–60.
Lewi H, Blumgart LH, Carter DC, et al. Pre-operative carcinoembryonic antigen and survival in patients with colorectal cancer. Br J Surg 1984;71:206–8.
Wolmark N, Fisher B, Wieand HS, Henry RS. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer: results from NSABP clinical trials. Ann Surg 1984;199:375–82.
Goldenberg DM, Sharkey RM, Primus FJ. Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens. Cancer 1978;42:1546–53.
Isaacson P, LeVann HP. The demonstration of carcinoembyronic antigen colorectal carcinoma and colonic polyps using an immunoperoxidase technique. Cancer 1976;38:1348–56.
Wagener C, Müller-Wallraf R, Nisson S, Gröner J, Breuer H. Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumors: correlation with CEA levels in plasma. J Natl Cancer Inst 1981;67:539–47.
O'Brien MJ, Zamcheck N, Burke B, Kirkham SE, Saravis CA, Gottlieb LS. Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissue: assessment of diagnostic value. Am J Clin Pathol 1981;75:283–90.
Nakopoulou L, Zinozi M, Theodoropoulos G, Papacharalampous N. Carcinoembryonic antigen detection by immunocytochemical methods in carcinomas of the colon and stomach. Dis Colon Rectum 1983;26:269–74.
Schoentag R, Williams V, Kuhns W. The distribution of blood group substance H and CEA in colorectal carcinoma. Cancer 1984;53:503–9.
Zamcheck N, Kupchik HZ. Summary of clinical use and limitations of the carcinoembryonic antigen assay and some methodological considerations. In: Rose NR, Friedman H, eds. Manual of clinical immunology, Washington, DC: American Society for Microbiology, 1980:919–35.
Phil E, McNaughlan J, Ma J, Ward HA, Nairn RC. Immunohistological patterns of carcinoembryonic antigen in colorecal carcinoma. Correlation with staging and blood levels. Pathology 1980;12:7–13.
Booth SN, King JP, Leonard JC, Dykes PW. Serum carcinoembryonic antigen in clinical disorders. Gut 1973;14:794–9.
Loewenstein MS, Zamcheck N. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer 1978;42:1412–8.
Moore TL, Kupchik HZ, Marcon N, Zamcheck N. Carcinoembryonic antigen assay in cancer of the colon and pancreas and other digestive tract disorders. Am J Dig Dis 1971;16:1–7.
Nicolson GL, Poste G. The cancer cell: dynamic aspects and modifications in cell-surface organization. N Engl J Med 1976;295:253–8.
Nagura H, Tsutsumi Y, Shioda Y, Watanabe K. Immunohistochemistry of gastric carcinomas and associated diseases: novel distribution of carcinoembryonic antigen and secretory component on the surface of gastric cancer cells. J Histochem Cytochem 1983;31:193–8.
Hamada Y, Yamamura M, Hioki K, Yamamoto M, Nagura H, Watanabe K. Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer: correlation with plasma carcinoembryonic antigen levels. Cancer 1985; 55:136–41.
Denk H, Tappeiner G, Eckerstorfer R, Holzner JH. Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation. Int J Cancer 1972;10:262–72.
Goslin R, O'Brien MJ, Steele G, et al. Correlation of plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. Am J Med 1981;71:246–53.
Bordes M, Michiels R, Martin F. Detection by immunofluorescence of carcinoembryonic antigen in colonic carcinoma, other malignant or benign tumours and non-cancerous tissues. Digestion 1973;9:106–15.
Rognum T, Elgjo K, Brandtzaeg P, Orjasaeter H, Bergan A. Plasma carcinoembryonic antigen concentrations and immunohistochemical patterns of epithelial marker antigens in patients with large bowel carcinoma. J Clin Pathol 1982; 35:922–33.
Author information
Authors and Affiliations
Additional information
Supported by a grant from the Veterans Administration.
About this article
Cite this article
Cunningham, L., Stocking, B., Halter, S.A. et al. Immunoperoxidase staining of carcinoembryonic antigen as a prognostic indicator in colorectal carcinoma. Dis Colon Rectum 29, 111–116 (1986). https://doi.org/10.1007/BF02555392
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02555392